Bedaquiline Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

A Pan-TB Regimen Targeting Host and Microbe
Condition:   Tuberculosis Interventions:   Drug: Sutezolid;   Drug: N-acetyl cysteine;   Drug: Pretomanid;   Drug: Bedaquiline;   Combination Product: Rifafour Sponsors:   The Aurum Institute NPC;   Ludwig-Maximilians - University of Munich;   Stichting Katholieke Universiteit;   Wits Health Consortium (Pty) Ltd;   Instituto Nacional de Saúde, Mozambique;   National Institute for Medical Research, Tanzania;   University of Stellenbos ch;   Sequella, Inc.;   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2023 Category: Research Source Type: clinical trials